ArticleFunctional & integrative genomics2026
Integrative transcriptomic profiling identifies LINC02365-associated regulatory networks in hepatocellular carcinoma.
Article in Functional & integrative genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
This study aimed to characterize candidate regulatory networks associated with LINC02365 knockdown using integrative transcriptomic profiling and Huh-7 cells as a model of hepatocellular carcinoma. LINC02365 expression was evaluated in TCGA-LIHC and GEO datasets and validated in Huh-7, SMMC7721, MHCC97-H, and LO2 cell lines by qRT-PCR. Huh-7 cells with stable LINC02365 knockdown were subjected to next-generation RNA sequencing. Differential gene expression analysis, Gene Ontology (GO) enrichment, KEGG and Reactome pathway analysis, protein-protein interaction (PPI) analysis, transcription factor annotation, microRNA-related analysis, fusion gene detection, alternative splicing analysis, and immune-related signature profiling were performed to define candidate regulatory networks associated with LINC02365 knockdown. LINC02365 was consistently upregulated in TCGA-LIHC and GEO datasets and in the examined HCC cell lines. Transcriptomic profiling following LINC02365 knockdown revealed widespread changes in gene expression. GO enrichment analysis showed significant associations with epithelial cell proliferation, cell adhesion-related processes, transcription factor regulation, inflammatory response-related terms, and extracellular matrix-associated functions. KEGG pathway analysis identified PI3K-Akt signaling as the most prominent candidate downstream pathway, whereas Reactome analysis highlighted extracellular matrix organization. In addition, LINC02365 knockdown was associated with broad changes in transcription factor-linked networks, microRNA-related networks, alternative splicing events, fusion gene profiles, and immune-related transcriptional signatures. This integrative transcriptomic analysis suggests that LINC02365 is associated with multilayered transcriptomic and regulatory changes in Huh-7 cells and provides a discovery-oriented framework for future functional and mechanistic investigation in hepatocellular carcinoma.
Indexed as
Identifiers
42219413What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.